BIT
ATYR

BlackRock Institutional Trust’s aTyr Pharma ATYR Stock Holding History

BlackRock Institutional Trust’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$762K Buy
25,325
+721
+3% +$29.6K ﹤0.01% 3361
2016
Q3 		$1.09M Buy
24,604
+17
+0.1% +$735 ﹤0.01% 3256
2016
Q2 		$957K Buy
24,587
+18,697
+317% +$869K ﹤0.01% 3318
2016
Q1 		$325K Sell
5,890
-66
-1% -$5.02K ﹤0.01% 3539
2015
Q4 		$820K Buy
5,956
+119
+2% +$16.9K ﹤0.01% 3377
2015
Q3 		$838K Buy
5,837
+3,090
+112% +$704K ﹤0.01% 3387
2015
Q2 		$712K Buy
+2,747
New +$853K ﹤0.01% 3439

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $92.2B AUM 15.8% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return